U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): March 11, 2004
COMMISSION FILE NUMBER: 000 32141
Nutra Pharma Corp.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
California 91-2021600
--------------------------------------- -----------------------
(State or jurisdiction of incorporation (I.R.S. Employer I.D. No.)
or organization)
4001 NW 73rd Way
Coral Springs, Florida 33065
--------------------------------------- -----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number: (954) 509-0911
-------------------------------------------------------------
(Former name or former address, if changed since last report)
Item 4. Changes in Registrant's Certifying Accountant
On March 11, 2004, the Registrant engaged the firm of Eisner, LLP, 750 Third
Avenue, New York, NY, as its new principal independent auditor to audit the
Registrant's financial statements.
SIGNATURES
-------------------
Pursuant to the requirements of the Securities Act of 1934, the Registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
1
Dated: March 11, 2004
Nutra Pharma Corp.
/s/ Rik Deitsch
---------------------------
By: Rik Deitsch
Its: Chief Executive Office
and Chief Financial Officer
CERTIFICATION
-----------------------
In connection with the current report of Nutra Pharma Corp. ("Company") on Form
8-K, dated March 11, 2004, as filed with the Securities and Exchange Commission
on the date hereof, Rik Deitsch certifies, pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to
the best of his knowledge:
1. The report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and
2. The information contained in the report fairly presents, in all material
respects, the financial condition and results of the Company.
Dated: March 11, 2004 /s/ Rik Deitsch
----------------------------
By: Rik Deitsch
Its: Chief Executive Officer,
And Chief Financial Officer
2